Literature DB >> 7872661

Isolation of a new vinca alkaloid from the leaves of Ervatamia microphylla as an inhibitor of ras functions.

K Umezawa1, T Ohse, T Yamamoto, T Koyano, Y Takahashi.   

Abstract

A new vinca alkaloid was isolated from a chroloform extract of Ervatamia microphylla leaves as a potent inhibitor of ras functions. The structure of the new alkaloid was elucidated by spectroscopic analysis to be a dimer of aspidosperma-class indoles. The new inhibitor, named III-121C, induced normal morphology in K-ras(ts)-NRK cells at around 0.3 microgram/ml. It also inhibited DNA, RNA, and protein synthesis weakly at 0.3 microgram/ml. It inhibited the growth of K-ras(ts)-NRK cells with IC50s of 0.29, and 0.20 microgram/ml at 33 degrees C and 39 degrees C, respectively. III-121C is the first vinca alkaloid that inhibits ras functions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7872661

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Conophylline protects cells in cellular models of neurodegenerative diseases by inducing mammalian target of rapamycin (mTOR)-independent autophagy.

Authors:  Yukiko Sasazawa; Natsumi Sato; Kazuo Umezawa; Siro Simizu
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

Review 2.  Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models.

Authors:  Kazuo Umezawa; Itaru Kojima; Siro Simizu; Yinzhi Lin; Hitomi Fukatsu; Naoki Koide; Yukiomi Nakade; Masashi Yoneda
Journal:  Hum Cell       Date:  2017-12-16       Impact factor: 4.174

3.  The plant alkaloid conophylline inhibits matrix formation of fibroblasts.

Authors:  Takehiko Tezuka; Akinobu Ota; Sivasundaram Karnan; Katsuhiko Matsuura; Kazuhisa Yokoo; Yoshitaka Hosokawa; Davide Vigetti; Alberto Passi; Sonoko Hatano; Kazuo Umezawa; Hideto Watanabe
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

4.  Conophylline inhibits non-alcoholic steatohepatitis in mice.

Authors:  Yukiomi Nakade; Kazumasa Sakamoto; Taeko Yamauchi; Tadahisa Inoue; Yuji Kobayashi; Takaya Yamamoto; Norimitsu Ishii; Tomohiko Ohashi; Yoshio Sumida; Kiyoaki Ito; Haruhisa Nakao; Yoshitaka Fukuzawa; Kazuo Umezawa; Masashi Yoneda
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

5.  Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor.

Authors:  H Tanaka; K Nishida; K Sugita; T Yoshioka
Journal:  Jpn J Cancer Res       Date:  1999-10

6.  Conophylline Suppresses Angiotensin II-Induced Myocardial Fibrosis In Vitro via the BMP4/JNK Pathway.

Authors:  S Q Zhang; Y N Bao; L Y Lv; X H Du; Y C Wang
Journal:  Bull Exp Biol Med       Date:  2021-07-24       Impact factor: 0.804

7.  Thermal Proteome Profiling Reveals Glutathione Peroxidase 4 as the Target of the Autophagy Inducer Conophylline.

Authors:  Junya Kakegawa; Satoshi Ohtsuka; Masahiro Yokoyama; Toru Hosoi; Koichiro Ozawa; Takashi Hatanaka
Journal:  Mol Pharmacol       Date:  2021-06-14       Impact factor: 4.054

8.  Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.

Authors:  Norihiro Ishii; Kenichiro Araki; Takehiko Yokobori; Kei Hagiwara; Dorgormaa Gantumur; Takahiro Yamanaka; Tadashi Handa; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Norifumi Harimoto; Atsushi Masamune; Kazuo Umezawa; Hiroyuki Kuwano; Ken Shirabe
Journal:  Cancer Sci       Date:  2018-12-13       Impact factor: 6.716

9.  Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.

Authors:  Tomohiko Ohashi; Yukiomi Nakade; Mayu Ibusuki; Rena Kitano; Taeko Yamauchi; Satoshi Kimoto; Tadahisa Inoue; Yuji Kobayashi; Yoshio Sumida; Kiyoaki Ito; Haruhisa Nakao; Kazuo Umezawa; Masashi Yoneda
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.